je.st
news
Apeiron Closes Regional License Agreement for Antibody-based Immunotherapy:
2013-01-18 16:57:27| Agriculture - Topix.net
Paladin Labs Inc. , one of Canada's leading specialty pharmaceutical companies, entered into an exclusive licensing agreement with Apeiron, under the terms of which Paladin receives the exclusive rights to market and sell APN311 in Canada and Sub-Saharan Africa .
Tags: agreement
license
regional
closes
Category:Agriculture and Forestry